G Doug Iiekking Sells 5,198 Shares of USANA Health Sciences, Inc. (NYSE:USNA) Stock

USANA Health Sciences, Inc. (NYSE:USNA) CFO G Doug Iiekking sold 5,198 shares of USANA Health Sciences stock in a transaction that occurred on Tuesday, May 7th. The stock was sold at an average price of $44.76, for a total transaction of $232,662.48. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

USANA Health Sciences Trading Up 0.7 %

Shares of NYSE:USNA opened at $45.07 on Thursday. The firm has a 50 day simple moving average of $46.42 and a 200-day simple moving average of $48.05. USANA Health Sciences, Inc. has a twelve month low of $41.45 and a twelve month high of $69.60. The company has a market capitalization of $865.34 million, a PE ratio of 14.04, a P/E/G ratio of 1.38 and a beta of 0.94.

USANA Health Sciences (NYSE:USNA) last announced its quarterly earnings results on Tuesday, February 6th. The company reported $0.87 earnings per share for the quarter, beating analysts’ consensus estimates of $0.52 by $0.35. USANA Health Sciences had a net margin of 6.88% and a return on equity of 12.80%. The firm had revenue of $221.08 million during the quarter, compared to analysts’ expectations of $206.70 million. As a group, equities research analysts predict that USANA Health Sciences, Inc. will post 2.75 EPS for the current fiscal year.

Analyst Ratings Changes

Several equities analysts recently commented on the company. DA Davidson dropped their target price on USANA Health Sciences from $48.00 to $46.00 and set a “neutral” rating on the stock in a report on Tuesday. StockNews.com upgraded USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a report on Friday, January 12th.

Institutional Trading of USANA Health Sciences

A number of hedge funds and other institutional investors have recently made changes to their positions in USNA. SG Americas Securities LLC acquired a new stake in shares of USANA Health Sciences in the 3rd quarter valued at about $581,000. Robeco Institutional Asset Management B.V. lifted its stake in USANA Health Sciences by 27.0% in the third quarter. Robeco Institutional Asset Management B.V. now owns 23,819 shares of the company’s stock valued at $1,396,000 after buying an additional 5,064 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in shares of USANA Health Sciences by 60.6% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,376 shares of the company’s stock valued at $198,000 after acquiring an additional 1,274 shares during the period. Strs Ohio grew its position in shares of USANA Health Sciences by 4.8% during the third quarter. Strs Ohio now owns 10,900 shares of the company’s stock worth $638,000 after acquiring an additional 500 shares during the last quarter. Finally, TD Asset Management Inc grew its position in shares of USANA Health Sciences by 16.2% during the third quarter. TD Asset Management Inc now owns 8,600 shares of the company’s stock worth $504,000 after acquiring an additional 1,200 shares during the last quarter. Institutional investors and hedge funds own 54.25% of the company’s stock.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.